Efficacy and safety of mifepristone–buccal misoprostol for early medical abortion in an Australian clinical setting

Goldstone, Philip; Walker, Clara; Hawtin, Katherine

doi:10.1111/ajo.12608

Cited by 37 publications

(56 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Nearly all of these women were counselled, screened and sent the medications within 15 days after initial registration. Of those with full follow up, 96% completed the abortion without surgical evacuation, consistent with outcomes of in‐person medical abortion . Only 5% of treated women required any subsequent face‐to‐face clinical encounter.…”

Section: Discussionmentioning

confidence: 57%

A direct‐to‐patient telemedicine abortion service in Australia: Retrospective analysis of the first 18 months

Hyland

Raymond

Chong

2018

Aust NZ J Obst Gynaeco

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 57%

A direct‐to‐patient telemedicine abortion service in Australia: Retrospective analysis of the first 18 months

Hyland

Raymond

Chong

2018

Aust NZ J Obst Gynaeco

View full text Add to dashboard Cite

show abstract

“…Until the early years of the 21st century, abortions were only performed surgically; the passing of the ‘Harradine amendment’ in Federal parliament in 1996 meant that mifepristone, already used in Europe, the United States (US) and elsewhere for medical abortion, was not available in Australia. This changed in 2006 when the Harradine amendment was overturned in parliament and mifepristone was gradually introduced into Australian practice, culminating in full licensing in 2012 and its addition to the Pharmaceutical Benefits Scheme in 2013 …”

Section: Introductionmentioning

confidence: 99%

Views and practices of induced abortion among Australian Fellows and trainees of The Royal Australian and New Zealand College of Obstetricians and Gynaecologists: A second study

Cheng

Black

Woods

et al. 2019

Aust NZ J Obst Gynaeco

View full text Add to dashboard Cite

Objectives Knowledge of current practices of abortion is important for planning of health services in Australia and for future training. Aims To conduct an online survey of the Fellows and specialist trainees of RANZCOG regarding their views and practices of induced abortion and compare these with results of a similar study from 2010. Methods and Materials A questionnaire was distributed to Australian Fellows and specialist trainees. Data collected were descriptively analysed and thematic analysis used for free comments. Results Approximately 25% of those emailed responded (632 of 2542); 13.7% reported total opposition to abortion on religious or conscientious grounds; the remainder did not. 83.5% believed that abortion should be part of general obstetric and gynaecological practice; 90% believed that education about abortion should be part of the curriculum for RANZCOG trainees. 92% supported public hospital provision of abortion services. A range of views was explored using thematic analysis. Discussion While a majority of Fellows and trainees do not hold religious or conscientious objections to abortion a significant minority do; this has changed little since 2010. Many respondents distinguish between ‘medical’ and ‘social’ indications for abortion although definitions of ‘social’ appear variable. There was strong support for the inclusion of abortion in the Fellowship training curriculum. Conclusion Although the response rate was lower than for the 2010 survey participants expressed strong support for the provision of abortion services in the public sector in Australia, and for incorporation of information about abortion in the training curriculum for Fellowship of RANZCOG.

show abstract

“…One approach to improve this inequitable situation is to increase the use of medication abortion (MA) in the primary health care (PHC) sector. The MA method, consisting of the sequential combination of mifepristone and misoprostol, can be legally and safely provided in the PHC setting for pregnancies up to 63 days since 2012 . This approach can complement two other currently applied MA provision models in Victoria: MA provided by Gateway Health, a primary health care service located in northeast Victoria, and MA provided through direct‐to‐consumer telemedicine .…”

Section: Introductionmentioning

confidence: 99%

Snapshot of medication abortion provision in the primary health care setting of regional and rural Victoria

Moel-Mandel

Graham

Taket

2019

Australian J Rural Health

View full text Add to dashboard Cite

Objective This study aimed to identify enablers and barriers to the provision of medication abortion in the primary health care setting of regional and rural areas of Victoria, Australia. Design An online cross‐sectional questionnaire was used. Setting Regional and rural areas of Victoria, Australia. Participants Thirty‐nine GPs and 30 primary health care nurses. Main outcome measures Abortion views, medication abortion knowledge and practice, interest in medication abortion training and provision, and perceived uptake barriers. Results Most participants reported being consulted by women with unintended pregnancies and most of them included abortion counselling in their consultation. However, familiarity with provision of medication abortion was limited, and only five GPs and two primary health care nurses were currently medication abortion providers. The majority of participants expressed a high level of interest in receiving medication abortion training, but indicated a wide range of barriers to service provision, such as a lack of training opportunities, legal uncertainties or surgical access concerns in case of complications. Conclusions Findings demonstrate the need for education on medication abortion and training opportunities. Most identified barriers to service uptake are addressable and relate to a lack of local support services, including the absence of a 24‐hour contact advice service, insufficient follow‐up access and a lack of local ultrasound facilities. These barriers require educational programs at professional, organisational and community level to ensure that interested rural and regional primary health care providers can start offering medication abortion for their patients.

show abstract

Efficacy and safety of mifepristone–buccal misoprostol for early medical abortion in an Australian clinical setting

Abstract: Mifepristone-buccal misoprostol is an effective and safe alternative to surgical termination of pregnancy up to 63 days gestation.

Cited by 37 publications

References 17 publications

A direct‐to‐patient telemedicine abortion service in Australia: Retrospective analysis of the first 18 months

A direct‐to‐patient telemedicine abortion service in Australia: Retrospective analysis of the first 18 months

Views and practices of induced abortion among Australian Fellows and trainees of The Royal Australian and New Zealand College of Obstetricians and Gynaecologists: A second study

Snapshot of medication abortion provision in the primary health care setting of regional and rural Victoria

Contact Info

Product

Resources

About